Wellumio secures $9.75M to develop portable MRI for bedside stroke imaging

Wellumio raised $9.75M to advance its portable, AI-powered MRI brain imaging system for point-of-care stroke diagnosis. The 110-lb device requires no cryogen or contrast and has shown agreement with conventional MRI in early studies.

• Oversubscribed pre-Series A round with new investments from Bioshore Ventures and Jumpspace Ventures.
• Funds will support workforce expansion, clinical validation, regulatory activities, and commercialization.
• The proprietary Pulsed Gradient Free Mapping technology recently received a U.S. patent.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.